Completion of US FDA Pre-Approval Inspection at Eugia Steriles Private Limited

The United States Food and Drug Administration (US FDA) conducted a PAI at Eugia Steriles Private Limited (a 100% subsidiary of Eugia Pharma Specialities Limited and a stepdown subsidiary of AUROBINDO PHARMA LIMITED), situated at Parawada Mandal, Anakapalli District, Andhra Pradesh, from June 10, 2026, to June 19, 2026.

The inspection concluded with 5 observations and will be responded to within the stipulated time.

The Company is committed to maintaining the highest quality manufacturing standards at all of its facilities across the globe. We will keep the stock exchanges informed if there is any further information relating to the above in the future.

Shares of Aurobindo Pharma Limited was last trading in BSE at Rs. 1497.85 as compared to the previous close of Rs. 1443.05. The total number of shares traded during the day was 121548 in over 3664 trades.

The stock hit an intraday high of Rs. 1502.85 and intraday low of 1447.60. The net turnover during the day was Rs. 178464025.00.

Source : Equity Bulls

Keywords

AurobindoPharma INE406A01037 Pharmaceuticals EugiaSteriles USFDA PAI 5Observations